Charles Argoff
Albany Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Charles Argoff as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:08 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06901518 · The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous HeadachesAlbany Medical College · completed · Post-Traumatic Headache · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:08 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.N Engl J Med · 19911,046 citationsRCR 28.6
- Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial.JAMA Neurol · 2021235 citationsRCR 19.5
- Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.Curr Med Res Opin · 200487 citationsRCR 2.8
- The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.Neurology · 199387 citationsRCR 2.2
- 85 citationsRCR 3.4
- Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.Curr Med Res Opin · 200469 citationsRCR 2.3
- Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.Curr Med Res Opin · 200452 citationsRCR 1.8
- Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial.Diabetes Res Clin Pract · 202343 citationsRCR 7.3
- 42 citationsRCR 3.9
- Effect of low-frequency deep brain stimulation on sensory thresholds in Parkinson's disease.J Neurosurg · 201726 citationsRCR 1.4